Schindler et al., 2008 - Google Patents
Reprint of classification and pharmacology of progestinsSchindler et al., 2008
View PDF- Document ID
- 5588074551248222021
- Author
- Schindler A
- Campagnoli C
- Druckmann R
- Huber J
- Pasqualini J
- Schweppe K
- Thijssen J
- Publication year
- Publication venue
- Maturitas
External Links
Snippet
Besides the natural progestin, progesterone, there are different classes of progestins, such as retroprogesterone (ie dydrogesterone), progesterone derivatives (ie medrogestone) 17α- hydroxyprogesterone derivatives (ie chlormadinone acetate, cyproterone acetate …
- 239000000583 progesterone congener 0 title abstract description 53
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/30—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schindler et al. | Reprint of classification and pharmacology of progestins | |
| Sitruk-Ware | Pharmacology of different progestogens: the special case of drospirenone | |
| Sitruk-Ware | New progestogens: a review of their effects in perimenopausal and postmenopausal women | |
| Krattenmacher | Drospirenone: pharmacology and pharmacokinetics of a unique progestogen | |
| Sitruk-Ware | Reprint of pharmacological profile of progestins | |
| Sitruk-Ware et al. | Nestorone®: clinical applications for contraception and HRT | |
| Stanczyk | All progestins are not created equal | |
| Sitruk-Ware | Progestogens in hormonal replacement therapy: new molecules, risks, and benefits | |
| Sitruk-Ware | New progestagens for contraceptive use | |
| Ruan et al. | The pharmacology of dienogest | |
| Sitruk-Ware et al. | Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills | |
| Kuhl | Pharmacology of estrogens and progestogens: influence of different routes of administration | |
| Kuhl | Comparative pharmacology of newer progestogens | |
| Mueck et al. | Nomegestrol acetate, a novel progestogen for oral contraception | |
| Stanczyk | Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception | |
| Sitruk-Ware et al. | The use of newer progestins for contraception | |
| Oelkers | Drospirenone, a progestogen with antimineralocorticoid properties: a short review | |
| US6500814B1 (en) | Hormonal contraceptive | |
| Kuhl | Pharmacokinetics of oestrogens and progestogens | |
| Ruan et al. | The pharmacology of nomegestrol acetate | |
| Fruzzetti et al. | Review of clinical experience with estradiol in combined oral contraceptives | |
| Regidor | Clinical relevance in present day hormonal contraception | |
| Simon | Estrogen replacement therapy: effects on the endogenous androgen milieu | |
| Grow | Metabolism of endogenous and exogenous reproductive hormones | |
| CA2194979C (en) | Solid drug forms containing clathrates of steroid sex hormones |